V. Ribon et al., Thiazolidinediones and insulin resistance: Peroxisome proliferator-activated receptor gamma activation stimulates expression of the CAP gene, P NAS US, 95(25), 1998, pp. 14751-14756
Citations number
26
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
c-Cbl-associated protein (CAP) is a signaling protein that interacts with b
oth c-Cbl and the insulin receptor that may be involved in the specific ins
ulin-stimulated tyrosine phosphorylation of c-Cbl. The restricted expressio
n of CAP in cells metabolically sensitive to insulin suggests an important
potential role in insulin action. The expression of CAP mRNA and proteins a
re increased in 3T3-L1 adipocytes by the insulin sensitizing thiazolidinedi
one drugs, which are activators of the peroxisome proliferator-activated re
ceptor gamma (PPAR gamma). The stimulation of CAP expression by PPAR gamma
activators results from increased transcription. This increased expression
of CAP was accompanied by a potentiation of insulin-stimulated c-Cbl tyrosi
ne phosphorylation. Administration of the thiazolidinedione troglitazone to
Zucker (fa/fa) rats markedly increased the expression of the major CAP iso
form in adipose tissue. This effect was sustained for up to 12 weeks of tre
atment and accompanied the ability of troglitazone to prevent the onset of
diabetes and its complications. Thus, CAP is the first PPAR gamma-sensitive
gene identified that participates in insulin signaling and may play a role
in thiazolidinedione-induced insulin sensitization.